Advil hearts menstrual cramps

Share this article:
Does Advil heart menstrual cramps?
Does Advil heart menstrual cramps?

In what seems an unusual marketing approach, Advil's South Korean consumer website is representing menstrual pain with a heart. At least, that's what's depicted on the Pfizer online property.

What's more, the heart is being formed by a man, in this case Olympic swimmer Park Tae-Hwan, who is shown making the symbol with his hands to demonstrate so-called "period pain" (pictured).

Tae-Hwan takes the body language metaphor further, depicting other types of pain the NSAID purports to address: his hands at his temples (headache), a hand brushed up against a cheek (dental pain, or toothache), and arms behind back (back pain).

As to the connection between a heart and menstrual pain, which, after all, is a feminine problem, or why the drugmaker chose to cross gender lines and get a man for the job, Pfizer offered the following statement: “Advil helps consumers relieve minor aches and pains due to headache, backache, toothache, menstrual cramps, muscle aches, minor pain of arthritis, the common cold and temporarily reduces fever. It is available in over 45 countries.”

Tae-Hwan—or “Marine Boy”—as he's sometime referred, is a member of the South Korean national swimming team. He won a gold medal in the 400-meter freestyle and picked up a silver medal in the 200-meter freestyle at the 2008 Summer Olympics in Beijing.

Pfizer launched Advil's Liqui-Gel formulation in South Korea this past December. Worldwide sales for Pfizer's consumer healthcare unit came in at $943 million for 2013, a 2% increase vs. the year prior.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.